KRAS and pancreatic neoplasm: In the case of pancreatic cancers, these include K-ras signaling, invasion, Small GTPase-signaling, apoptosis, integrin signaling, DNA damage control, notch signaling, and JNK signaling – all pathways that converge on eIF4E [35]–[41].